Date: 23 Feb 2011
Noninvasive Assessment of HIV-related Coronary Artery Disease
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Highly active antiretroviral therapy has led to significant declines in infection-related mortality in HIV-infected patients. Cardiovascular disease has emerged as a leading cause of morbidity and mortality in this population, and is likely related to both an increased prevalence of traditional cardiovascular risk factors and HIV-specific factors associated with antiretroviral therapy, chronic inflammation, and direct viral effects. Accurate clinical assessment of cardiovascular risk in HIV-infected patients is a critical challenge now facing practitioners. Multiple modes of noninvasive vascular imaging are available to enhance the ability to identify patients at high cardiovascular risk, and may ultimately assist in targeting use of intensive medical therapy to reduce cardiac events in this population. This review will examine several of these noninvasive tests and is intended to aid practitioners making cardiovascular risk assessments in HIV patients.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006;145:397–406.PubMed
The Data Collection on Adverse Events of Anti-HIV Drugs Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.CrossRef
Wilson PWF, D’Agostino RB, Levy D, Albert AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–43.PubMed
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel, III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143.
• Rossi R, Nuzzo A, Guaraldi G, Orlando G, Squillace N, Ligabue G, et al. The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infection. J Acquir Immune Defic Syndr. 2009;52:303–304. Demonstrates cardiovascular risk in young asymptomatic HIV patients with that of a high-risk population. PubMedCrossRef
Guimaraes MM, Greco DB, Garces AH, de Oliveria AR, Foscolo RB, Machado LJ. Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions. Int J Clin Pract. 2010;64:664–6.CrossRef
Knobel H, Jerico C, Montero M, Sorli M, Velat M, Guelar A, et al. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE and PROCAM). AIDS Patients Care STDs. 2007;21:452–7.CrossRef
The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723–35.CrossRef
Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:1496–508.CrossRef
Chan W, Sviridov D, Dart AM. HIV, atherosclerosis and inflammation: implications for treatment. J HIV Ther. 2009;14:61–8.PubMed
•• Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AS, De Wit S, et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on the adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil. 2010;5:491–501. Study using DAD study data to develop a more accurate clinical prediction score specifically for HIV-positive patients on ART.
Rumberger JA, Simons DB, Fitzpatrick LA. Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;95:2157–62.
Greenland P, Bonow RO, Brundage BH. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 2007;49:378–402.PubMedCrossRef
Acevedo M, Sprecher DL, Calabrese L, Pearce GL, Coyner DL, Halliburton SS, et al. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: a call for cardiovascular prevention. Atherosclerosis. 2002;162:349–54.CrossRef
Meng Q, Lima JAC, Lai H, Vlahov D, Celentano DD, Strathdee SA, et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte colume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am Heart J. 2002;144:642–8.PubMed
•• Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS. 2010;24:243–53. Important study using coronary CTA to demonstrate the prevalence of noncalcified coronary plaques in asymptomatic HIV patients. PubMedCrossRef
Chambless LE. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146:483–94.PubMed
Bots M. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–7.PubMed
Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasouns to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008;21:93–111.PubMedCrossRef
Maggi P. Premature leasions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS. 2000;14:123–8.CrossRef
Solanges A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, et al. Endothelial function in HIV-infected patients. Clin Infect Dis. 2006;42:1325–32.CrossRef
• Ross AC, Rizk N, O’Riordan MA, Dogra V, El-Bejjani D, Storer N, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009;49:1119–27. Further exploration of the connection between inflammation, vascular health, and atherosclerosis.PubMedCrossRef
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106:1883–92.PubMedCrossRef
Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.
Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53:2201.PubMedCrossRef
• Lytwin M, Fallah-Rad N, Walker J, Bohonis S, Hussain F, Barac I, et al. The utility of dobutamine stress echocardiography for the diagnosis of coronary artery disease in the HIV population. Echocardiography. 2010;27: 1228–1232. One of the only studies of stress testing performed in a specifically HIV-positive cohort. CrossRef
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–96.CrossRef
US Preventative Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005;142:198–202.
Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:2182–99.CrossRef
U.S. Preventive Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med. 2004;140:569–72.
- Noninvasive Assessment of HIV-related Coronary Artery Disease
Current HIV/AIDS Reports
Volume 8, Issue 2 , pp 114-121
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Human immunodeficiency virus (HIV)
- Coronary artery disease
- Cardiovascular risk stratification
- Industry Sectors